Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
CAH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$96.05 - $168.44
Previous CloseN/A
Volume818.36K
Average Volume (3M)1.96M
Market Cap
$37.23B
Enterprise Value$38.61B
Total Cash (Recent Filing)$3.33B
Total Debt (Recent Filing)$7.68B
Price to Earnings (P/E)24.4
Beta0.45
Next Earnings
Aug 12, 2025EPS Estimate
2.03Last Dividend Ex-Date
Jul 01, 2025Dividend Yield1.3%
Share Statistics
EPS (TTM)2.35
Shares Outstanding238,677,000
10 Day Avg. Volume1,724,914
30 Day Avg. Volume1,958,688
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue0.17
Enterprise Value/Gross Profit4.97
Enterprise Value/Ebitda13.72
Forecast
1Y Price Target
$178.17Price Target Upside14.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company raised its guidance for the fiscal year, demonstrating confidence in its future performance.
Revenue And Growth PotentialManagement expects the specialty segment to remain a key growth driver, with significant revenue and growth potential.
Strategic InvestmentsManagement is making smart strategic moves to accelerate investments in specialty areas and focus on differentiated offerings like Nuclear and At-Home.
Bears Say
CompetitionThe Pharma segment has been repositioned for faster growth, resulting in an impressive increase in EBIT long-range projections, yet the market remains highly competitive.
Market ChallengesThe company is managing tariff headwinds effectively while continuing to pursue strategic opportunities such as tuck-in M&A and buybacks.
Cardinal Health News
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $96.05 and its highest was $168.44 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $37.23B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 12, 2025 which is in 8 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on May 01, 2025. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.174 by $0.176.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.511 which represents an annual dividend yield of 1.3%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 2.03.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 238,677,000 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $2.35 in its last earnings report, beating expectations of $2.174. Following the earnings report the stock price went up 3.003%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
Cardinal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$178.17 (14.21% Upside)
$178.17 (14.21% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 455.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.25%
12-Months-Change
Fundamentals
Return on Equity
-43.80%
Trailing 12-Months
Asset Growth
8.70%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
CAH Company Deck
CAH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, strategic customer onboarding, and successful acquisitions, contributing to positive growth. However, challenges in the GMPD segment due to tariff impacts posed significant concerns, which the company is actively working to mitigate.Read More>CAH Revenue Breakdown
92.59% Pharmaceutical and Specialty Solutions
5.46% Global Medical Products and Distribution
1.99% Other
CAH Stock 12 Month Forecast
Average Price Target
$178.17
▲(14.21%Upside)
Technical Analysis
Ownership Overview
0.25% Insiders
22.43% Mutual Funds
1.11% Other Institutional Investors
47.61% Public Companies and Individual Investors